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Introduction
While the health-related benefits of intimate partnership are well documented (Kiecolt-Glaser and Newton, 2001; Lewis et al., 2006) , little attention has been paid to couples experiencing high levels of social stigma and exclusion, such as those who inject drugs and are affected by the hepatitis C virus (HCV) . In Australia, approximately 90% of newly-acquired HCV infections are due to the sharing of contaminated injecting equipment (The Kirby Institute, 2015) . Australia's primary public health response to HCV is focused on the distribution of sterile equipment (along with safer injecting advice) via government-funded needle syringe programmes (Treloar and Fraser, 2007) .
Integral to the prevention response has been the long-held understanding that avoiding transmission is a matter of individual responsibility (Dwyer et al., 2011; Fraser, 2004; Fraser et al., 2014) . This is reflected and reinforced not only through the prevention education and health promotion materials produced for people who inject drugs (PWID) (Dwyer et al., 2011; Fraser, 2013) , but the practical measures designed to enable the fulfilment of this responsibility, such as the ways in which sterile injecting equipment is distributed (Fraser et al., 2014) . Despite epidemiological and surveillance data consistently showing that the majority of equipment sharing occurs between sexual partners, this onus on individual responsibilisation has effectively elided the importance of the intimate partnership as a key site of hepatitis C prevention and transmission (El-Bassel et al., 2014; Fraser, 2013; Rhodes and Quirk, 1998; Seear et al., 2012; Simmons and Singer, 2006) . Recent survey data, for example, indicate that over 50% of participants who reported sharing injecting equipment did so with their regular sexual partner (Iversen and Maher, 2015) , with similar patterns found in earlier studies (Roux et al., 2014; Bryant et al., 2010; Cao and Treloar, 2006) . This "individualising tendency" has important implications for efforts to understand and prevent the transmission of hepatitis C, particularly within couples where arguably the risk is greatest. In this article we address this tendency by adopting a methodology that positions partnerships rather than individuals as the primary unit of analysis (Eisikovits and Koren, 2010; Simmons and Singer, 2006) . Drawing on qualitative interviews with couples who inject drugs, we focus on those couples that reported changes in HCVstatus (or "sero-change"). We explore how these participants responded to sero-changes within the lived contexts of their intimate partnerships and how such changes affected their perceptions of transmission risk.
Framing participants' partnerships as the primary unit of analysis represents a novel and instructive way of thinking about HCV transmission and prevention. Rarely have the intimate partnerships of PWID been conceptualised as units of analysis in their own right, tending to be either overlooked or discounted as dysfunctional and drug-driven (Fraser, 2013; Keane, 2004; Seear et al., 2012; Simmons and Singer, 2006) . Recently there has been an emergence of HIV-related research focussing on the "micro-social contexts" of heterosexual couples who inject drugs (El-Bassel et al., 2014; Montgomery et al., 2012) . This work emphasises the need to move beyond individual-level, cognitive-based models of health behaviour, underscoring instead the importance of a conceptual, motivational and "ideological shift from focusing on the individual to the dyad" (Jiwatram-Negron and El-Bassel, 2014, p. 1885) -from an orientation of "self-care" and "independence" to one prioritising "relationship", "interdependence" and "communal coping" (Montgomery et al., 2012) . In this article we build on these broad conceptual concerns via new empirical territory: an exploration of the particularities of acquiring and living with HCV among couples who inject drugs. Here a qualitative approach is not only well suited to capturing the richness and subtleties of contextualised, interpersonal dynamics, it is also particularly effective when exploring new and under-developed areas of research such as people's accounts of sero-change (Patton, 2002) .
Materials and methods

Recruitment and data collection
This project used purposive sampling to recruit heterosexual couples in which both partners identified as PWID. Recruitment took place across four harm-reduction, inner-city services within two Australian states, New South Wales and Victoria. Couples were included on the basis that both partners agreed to be interviewed. Each partner was interviewed separately by the same researcher, with assurances of confidentiality emphasised.
Interviewing partners separately, it was felt, would best facilitate the emergence of sensitive intra-relationship talk (Eisikovits and Koren, 2010) : the attribution of responsibility (or "blame") for HCV transmission within couples, for example. Semi-structured interview schedules were organised around the core themes of injecting drug use, HCV, and intimate partnership. Interviews took between 30 and 60 minutes. Each participant was reimbursed $30 to cover time and travel expenses.
Data management
The total dataset comprised 80 qualitative, in-depth interviews 1 . All interviews were digitally recorded, transcribed verbatim, de-identified and anonymised with the use of pseudonyms. A coding frame was developed collaboratively by the authors, drawing on the data itself, the interview schedule, and our knowledge of the literature. Consistent with positioning "the partnership" as the basic unit of analysis, transcripts were entered as couples within a qualitative data management program, NVivo 9. Consequently, any narrative detail extracted for analysis was readily identifiable as part of a broader story of partnership rather than simply an individual account. Individual theme files or 'nodes' were reviewed by all authors to assist with identifying and consolidating key themes and concepts. The data analysed in this article comprised 28 of the total 80 interviews, collected from the 14 couples that reported changes in HCV status during the course of their relationship. Our focus was on the node that collated all data concerned with couples' accounts of sero-change.
Analysis
Our analysis was conducted using a mix of inductive (data-driven) and deductive (analyst-driven) approaches (Braun and Clarke, 2006) . Induction enabled key themes to be identified in the relevant node and subsequently corroborated against the original transcripts.
These emergent themes plus indicative quotes were discussed among all authors. During this stage, summary accounts of each couples' sero-change story were also mapped out (see Table   1 ). Accounts from some participants included recollections of confusion or "misinformation" regarding their status; others described being uncertain, even perplexed, regarding the circumstances of transmission. Within couples, too, partners sometimes made contradictory statements about the other's status. A deductive analytical approach enabled us to begin to make sense of this apparent confusion or "mess". The extant literature, including our own earlier analyses of the dataset (see for example, Rance et al., 2016; Treloar et al., 2015) , provided an analytical framework through which to interpret couples' often complex accounts of sero-change. Our final analysis, including the three themes under which our results are organised, reflect these elements of grounded analysis (Glaser and Strauss, 1967) coupled with analyst-driven deduction. Throughout the writing process, each subsequent iteration incorporated suggestions from all authors, with differences negotiated until agreement was reached.
The study was approved by the Human Research Ethics Committee of The University of New South Wales (reference HC12430). Written, informed consent was obtained from all participants. All extracts cited here are identified by the participant's pseudonym, age and self-reported HCV status 2 (at time of interview), followed by their partner's corresponding details, and the duration of their relationship.
Results
The 28 participants ranged in age from 23 to 61 years; their relationships varied in duration from 10 months to 15 years. Twelve participants identified as 'Anglo-Australian' or 'Anglo-New Zealander', nine as Aboriginal and Torres Strait Islander, and the remainder as Australian-Armenian (n = 2), Greek-Italian (n = 2), Hungarian (n = 1), Scandanavian (n = 1) and Indian (n = 1). Three quarters of participants (n = 21) received some form of social welfare, five worked full-time (n = 3) or part-time (n = 2), one was dependent on his partner's income and one declined to answer. Based on self-reported status at the time of interview, two couples identified themselves as HCV-negative, four couples as HCV-positive, and the remaining eight as serodiscordant. The couples reported a total of thirteen seroconversions (including two instances alternatively described as "clinical mistakes"), eight exposures-plusspontaneous-clearances and two successful treatment outcomes.
This section explores participants' accounts of sero-change via three themes identified in the data: negotiating new diagnoses and accommodating chronic infections; status confusion; and the prioritisation of partnership.
Sero-change: new diagnoses and chronic infections
While participants' accounts of negotiating a new diagnosis within the context of intimate partnership varied markedly according to the relational, social and viral specificities of their situationincluding stated beliefs regarding the source of transmissionthey invariably shared an overarching concern for the effect it might have on their relationship. "It's almost like having to tell your partner you're pregnant or something, it's really fucking scary … it tests your relationship, it really does." (Crissy30neg following spontaneous clearance, Charlie34neg, 10 years) "I hate it, I was so ashamed, and I didn't tell [partner Dan] that I had caught it off him for, say, like 13 months …. "
(Debbie33pos, Dan33pos, 14 years)
"I didn't contract genotype 3 until a lot later in life. I was only diagnosed with that in the last 18 months … It's most probable that I got it from [Suzie] … I'm very happy and lucky in the sense that I'm glad that she hasn't got my genotype 1, which seems to be a bit more problematic at times for people."
(Seth34pos, Suzie46pos, 2 years)
Crissy recalled feeling bewildered by her diagnosis, stating she had "never shared or used someone else's needles". Nonethess, these feelings were ultimately secondary to her fear of transmitting the virus to her partner in the period before her spontaneous clearance was identitied: "the guilt would just kill me". For Debbie, her reluctance to tell her partner Dan was bound up with feelings of shame but also her desire to protect him from similarly uncomfortable emotions: "I didn't want him to blame himself and feel bad, because it wasn't his fault that he got it either." However, for Seth (already living with genotype 1), "It was kinda just like acceptance. I was more concerned when the results were coming back that 'please don't let [Suzie] get what I've got.'" Participants reported a range of emotional, discursive, and practical concerns and accommodations to living with long-term sero-change within their partnerships. Beyond a shared expression of concern among parenting participants about preventing household transmission to children, these accounts were diverse. For Fran, who reported seroconverting via her partner Fred and initially feeling "devastated", living with HCV "actually hasn't been like a big thing". Fred reported that his one concern was "that I don't want her to feel angry if she feels I gave it to her." Partners Debbie and Dan adopted a strategy of relative "serosilence" (Persson, 2008) in what appeared to be a mutual (if unspoken) effort to normalise their relationship in the face of internalised stigma and shame. For Jenn and Jimmy, who both reported seronverting whilst together but expressed uncertaintly about the source of transmission, their confusion emerged from time to time in moments of tension within their relationship.
"It's a hard thing to talk about … you try and keep it as low as possible. We've had a few talks about it, but not as much as we should." In addition to HCV-related confusion and uncertainty among participants, there were several sets of partners whose respective accounts of status appeared to be in clear contradiction. Debbie believed she was still living with a chronic infection, while her partner Dan expressed the conviction that she had cleared it. Karen and Keith both reported seroconverting twice, yet Karen also reported clearing her infections on both occasions; Keith, however, believed that she, like himself, was still HCV-positive. Tegan and Terry's accounts provided another permutation: while Tegan was adamant she had contracted HCV via Terry, Terry himself reported never having been HCV-positive. While Tegan agreed that Terry was no longer HCV-positive, she argued that he had either "secretly" undergone treatment in prison or had spontaneously cleared it.
Prioritising partnership
Accompanying participants' diverse, sometimes contraditory, accounts of negotiating HCV within their relationships was an important series of statements in which the centrality of the partnership, and its priority over HCV-related concerns, was articulated. Libby's response to her partner's diagnosis (from an unknown source) captures the essence of this commitment: "Well, I just said to him, 'don't think I'm going to leave you over it or anything like that', because I didn't want him to worry" (Libby26neg.; Les55pos.,1 year).
Similarly, Debbie reported insisting to her partner that, despite his responsibility for her contracting HCV, "I'm always going to be with you, so don't worry!" For Janine, the "good responsibility" her partner Jim had consistently demonstrated around the management of his HCV helped consolidate their relationship, making her feel cared for and "valued" (Janine48neg. following spontaneous clearance; Jim61pos., 15 years). Her suggestion that HCV-positive partners can demonstrate their love and support by making sure that they "deal with it" was reiterated by a number of participants . As Libby (cited above) went on to explain: while she did not want Les to worry, "I wanted him to learn about [HCV]". This He's very knowledgeable in that area; more so than me … Now I've got to do 6 months of interferon to correct my carelessness in the past."
(Suzie46pos, Seth34pos, 2 years)
While some participants acquired or sought greater biomedical understanding as a means of coming to terms with sero-change, others employed explanatory frameworks that sat firmly outside conventional biomedical discourse. Drawing on a number of alternative logics or "rationalities", these participants were primarily concerned with limiting the potential social and relational damage associated with contracting HCV. The virus itself meant something different when transmitted within the partnership rather than outside it.
Jenn, for example, explained the difference between Jimmy's experience of contracting HCV via a friend's "betrayal" and, years later, their experience together when she seroconverted. heart. Now my mate, we could be mates for years [but] the main thing in his head though is not going to be 'Oh fuck, I hope he doesn't get sick or anything', you see where I'm going?
So there's that emotional connection with [a partner] as well as just the fact we're friends or we use together." (Tim39neg, Tanya23pos, 9 years) "I don't really use [injecting equipment] after anyone. Only like my partner or my sister or my real close cousin. Because they're family. Like with my sister, we got the same blood." (Karen40pos, Keith32neg, 8 years) 
Discussion
In this article we have focussed on participants' accounts of changing HCV-status within the context of their intimate partnerships. While some couples sought greater biomedical understanding as a means of coming to terms with sero-change, others drew on alternative rationalities that sat firmly outside conventional biomedical discourse. Regardless of which explanatory framework they drew on, participants ultimately prioritised the security of their relationship over the dangers of viral infection. The intimate partnerships of PWID may function as forms of social care and protection in relation to typically hostile social environments and structural vulnerability (Seear et al., 2012) . As Rhodes and Cusick (2000) suggest, "efforts to protect intimacy and relationships from risk may be particularly important in lives perceived to be particularly insecure or continually under threat" (p.4). Among people who are socially excluded, including many who inject drugs, meaningful intimate relationships may provide one of the few forms of social capital available to them (Stevenson and Neale, 2012) . We need to recognise then, that within such partnerships the negotiation of risk is as much an enactment of emotional intimacy as of reasoned action: that ensuring the ongoing maintenance of the relationship is itself a form of risk management (Rhodes and Quirk, 1998) . As our findings suggest, participants frequently prioritised the securitythe 'emotional refuge' (Syvertsen et al., 2013 )of intimate partnership over competing concerns, including those of viral safety.
Enacting effective prevention and care, we argue, requires moving beyond the employment of narrowly-defined, individual-level psychological models of behaviourbeyond simple injunctions to take "individual responsibility" (Fraser, 2004 )to acknowledge the often complex interpersonal, social and structural imperatives governing intimate (and other) relationships among PWID. We need to better acknowledge and work with the competing priorities and complex realities of such partnerships beyond simply the identification of viral risk. We need to recognise that, as Hepworth and Krug (1999) argue, "While medical and psychological knowledge are necessary and relevant in the case of HCV, they are not the sole basis, nor necessarily the primary basis, on which individuals act" (p.
245).
We recognise that this study was designed in ways that could affect the findings. We have drawn on couples that reported changes in HCV-status whilst remaining together.
Consequently there was less likelihood of attracting accounts from couples for whom the pressure of status change contributed to the end of their relationship. More broadly, recruitment required self-selection and participation from both partners. This too may have shaped the dataset and the kinds of partnerships studied; it could have, for example, reduced the likelihood of making contact with couples affected by inter-partner violence and abuse.
While we noted a general absence of gendered inequity within our dataset (only two female participants provided explicit accounts of diminished power and agency within their relationship) we cannot be sure that such experiences were not more widespread.
Participants were adept at accommodating changes to status within the lived contexts of their private lives and relationships. For our participants, the meaning of risk and safety was multiple, socially and relationally situated, rather than singular, fixed and pre-determined. Even serodiscordance itself was perceived in diverse and unexpected ways, encompassing a range of meanings and practices among participants (Persson, 2013) . This is perhaps not surprising, given that, as others have argued (Fraser and Seear, 2011; Hepworth and Krug, 1999) , the meanings of diagnosis and living HCV are "embedded" within the social and cultural dimensions of everyday life and relationships. Participant accounts of status confusion and contradiction, of doctor's mistakes and lay (mis)understandings, need to be balanced against the limitations of conventional biomedical approaches to HCV education and care. Social researchers have consistently described the disconnection reported between people's lived experience of HCV and biomedical concerns focussed solely on the physical body (Harris, 2005; Krug, 1995; Sutton and Treloar, 2007) . As Treloar and Rhodes (2008) argue, biomedical responses can be "at extreme odds with the situated and competing priorities of people who inject drugs" (p. 1330). Nonetheless, our results do suggest the need to continually engage those who inject drugs, in both HCV testing and in improving the systems by which these tests and resultant information are provided. With the "new era" of direct acting antiviral treatments promising to profoundly change what it means to acquire and live with HCV, opportunities will arise to learn to integrate biomedical information within more socially sophisticated, relationally aware approaches.
Notes
1. The 80 respondents were comprised of 34 couples, plus 12 "sole" participants included on the basis of having had relationship experience (prior or current) involving injecting drug use.
2. Our use of terms in this paper refers to HCV-status as it relates to the potential for transmission.
"HCV-positive" refers to chronic infection (antibody-positive and RNA-positive); such a person is infectious to others. "HCV-negative" refers to people without chronic infection (that is, antibody-negative and RNA-negative, or antibody-positive and RNA-negative); such a person is not infectious to others. "Exposure" refers to an exposure to HCV which did not result in chronic infection (antibody-positive and RNA-negative). "Seroconversion" refers to exposure to HCV which did result in HCV chronic infection (antibody-positive and RNApositive). We use the term "sero-change" as a catchall to describe any change in HCV-status reported by participants.
3.
A PCR test can detect infectious agents directly, as opposed to antibodies which are produced in response to infection (Dore, 2009) . Approximately 25% of people exposed to HCV do not go on to develop chronic infections but will nonetheless remain "antibodypositive". A PCR test should therefore be included as part of a complete virological assessment in order to avoid confusion. 
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Janine48neg / Jim61pos (15 yrs.)
1 seroconversion + post-pregnancy clearance Initially serodiscordant. Janine reported subsequent seroconversion following accidentally sharing a needle-syringe with Jim. She reported clearing the virus following the birth of their child three years later.
Fran29pos / Fred29pos (8 yrs.)
1 seroconversion or "clinical mistake"
seroconversion
Initially negative seroconcordant. Fred reported a previous HCV-positive diagnosis but a "negative" result at the start of the relationship. Believed his HCV had subsequently either "come back" or that the clinician had been mistaken regarding his earlier "negative" result. Fran reported contracting HCV after the relationship commenced, via Fred.
Debbie33pos / Dan33pos (14 yrs.)
1 seroconversion Initially serodiscordant. Debbie reported subsequently contracting HCV via Dan and remaining HCV-positive. Dan agreed he "gave it" to Debbie but believed she had subsequently cleared her infection.
Keith40pos / Karen32neg (8 yrs.)
2 exposures + spontaneous clearance 1 seroconversion Initially positive seroconcordant. Both claimed to have been HCV-positive twice. Karen: "I had hep C and then it went away and come back and now it's gone"; Keith: "I've got rid of it and got it again … I feel stupid". Although unclear, it seems Keith's latest infection was acquired during his relationship with Karen but not via her. Karen reported she had been exposed to the virus twice during the relationship (at least once via Keith) but is now HCVnegative. Keith, however, believes they are both still HCV-positive. Accounts suggest Karen began injecting drug use after the relationship began.
Terry37neg / Tegan38pos (6 yrs.)
seroconversion
Initially negative seroconcordant. Tegan reported subsequently contracting HCV via Terry except he reports always being HCV-negative.
Jenn31pos / Jimmy32pos (6 yrs.)
1 seroconversion or "clinical mistake" 1 seroconversion Initially negative seroconcordant. Both reported being diagnosed HCV-positive after beginning relationship: Jenn for the first time; Jimmy for the second. Jimmy reported receiving a "positive" diagnosis years earlier before later being told by a clinician that he had cleared the infection. Suggested he then "got it again" after he started injecting with Jenn. Jenn, however, believed Jimmy's doctor had made a mistake and that Jimmy had not cleared his initial infection. Jenn reported contracting HCV since meeting Jimmy but was unclear about source of transmission.
